Grit Hutter

469 total citations
29 papers, 313 citations indexed

About

Grit Hutter is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Grit Hutter has authored 29 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 17 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Grit Hutter's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (6 papers). Grit Hutter is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (6 papers). Grit Hutter collaborates with scholars based in Germany, Czechia and Spain. Grit Hutter's co-authors include Martin Dreyling, Wolfgang Hiddemann, Yvonne Zimmermann, Alessandro Pastore, Martin Dreyling, Aniruddha J. Deshpande, Anagha Deshpande, Malte Rieken, Christian Buske and Georg Lenz and has published in prestigious journals such as Blood, Oncogene and Drugs.

In The Last Decade

Grit Hutter

29 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grit Hutter Germany 10 185 151 117 84 60 29 313
Ana I. Sáez Spain 7 148 0.8× 181 1.2× 194 1.7× 78 0.9× 39 0.7× 8 340
Hilka Rauert‐Wunderlich Germany 9 87 0.5× 124 0.8× 132 1.1× 62 0.7× 43 0.7× 16 262
Isabel Romero-Camarero Spain 7 191 1.0× 175 1.2× 172 1.5× 73 0.9× 66 1.1× 11 412
Hannelore Madle Germany 5 159 0.9× 173 1.1× 142 1.2× 117 1.4× 82 1.4× 6 347
Viktor Ljungström Sweden 11 139 0.8× 110 0.7× 70 0.6× 127 1.5× 78 1.3× 23 323
G Stranks United Kingdom 7 125 0.7× 153 1.0× 182 1.6× 93 1.1× 28 0.5× 8 331
Irina Idler Germany 6 143 0.8× 123 0.8× 121 1.0× 123 1.5× 52 0.9× 8 311
Francis LeBlanc United States 8 171 0.9× 115 0.8× 102 0.9× 109 1.3× 48 0.8× 15 377
Kerstin Dietze Germany 6 125 0.7× 147 1.0× 137 1.2× 96 1.1× 76 1.3× 8 319
Tatjana Walther Germany 6 171 0.9× 54 0.4× 79 0.7× 46 0.5× 84 1.4× 7 317

Countries citing papers authored by Grit Hutter

Since Specialization
Citations

This map shows the geographic impact of Grit Hutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grit Hutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grit Hutter more than expected).

Fields of papers citing papers by Grit Hutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grit Hutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grit Hutter. The network helps show where Grit Hutter may publish in the future.

Co-authorship network of co-authors of Grit Hutter

This figure shows the co-authorship network connecting the top 25 collaborators of Grit Hutter. A scholar is included among the top collaborators of Grit Hutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grit Hutter. Grit Hutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutter, Grit, et al.. (2016). Mode of action of different PI3K-inhibitors in mantle cell lymphoma. Haematologica. 1 indexed citations
2.
Seiler, Till, Grit Hutter, & Martin Dreyling. (2016). The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date. Drugs. 76(6). 639–646. 16 indexed citations
3.
4.
Hutter, Grit, et al.. (2015). Temsirolimus acts as additive with bendamustine in aggressive lymphoma. Annals of Hematology. 95(3). 403–407. 7 indexed citations
5.
Hutter, Grit, Malte Rieken, Alessandro Pastore, et al.. (2012). The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma. Annals of Hematology. 91(6). 847–856. 28 indexed citations
6.
Dreyling, Martin, Hanneke C. Kluin‐Nelemans, Sı́lvia Beà, et al.. (2012). Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network. Leukemia & lymphoma. 54(4). 699–707. 39 indexed citations
7.
Dreyling, Martin, Eva Hoster, Sı́lvia Beà, et al.. (2010). Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference. Leukemia & lymphoma. 51(9). 1612–1622. 14 indexed citations
8.
Hutter, Grit, Yvonne Zimmermann, Malte Rieken, et al.. (2010). Enzastaurin Treatment Affects Multiple Regulatory Pathways at Transcriptome and Cellular Proteome Level of Mantle Cell Lymphoma. Blood. 116(21). 2893–2893. 1 indexed citations
9.
Heinrich, Daniel, et al.. (2010). Differential Regulation Patterns of Anti-CD20 Antibodies GA101 and Rituximab in Mantle Cell Lymphoma. Blood. 116(21). 1839–1839. 1 indexed citations
10.
11.
Deshpande, Anagha, Alessandro Pastore, Aniruddha J. Deshpande, et al.. (2009). 3’UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle. 8(21). 3592–3600. 67 indexed citations
12.
Zimmermann, Yvonne, Elena Hartmann, Andreas Rosenwald, et al.. (2009). 2‐D PAGE‐based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma. Electrophoresis. 30(6). 974–986. 17 indexed citations
13.
Hutter, Grit, German Ott, Yvonne Zimmermann, et al.. (2009). Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation. Annals of Hematology. 88(9). 821–828. 2 indexed citations
14.
Klein, Christian, et al.. (2009). Anti-CD20 Antibody GA101 Shows Higher Cytotoxicity but Is Competitively Displaced by Rituximab in Mantle Cell Lymphoma.. Blood. 114(22). 2704–2704. 1 indexed citations
15.
Hutter, Grit, Jörg Kalla, Elena Hartmann, et al.. (2008). Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma. Journal of Hematopathology. 1(2). 85–95. 4 indexed citations
16.
Šmardová, Jana, Tiemo Katzenberger, Sylvia Höller, et al.. (2007). Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma. Oncogene. 27(18). 2613–2625. 24 indexed citations
17.
Hutter, Grit, Yvonne Zimmermann, Tiemo Katzenberger, et al.. (2005). Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes and Cancer. 45(2). 203–210. 29 indexed citations
18.
19.
Hutter, Grit, Christina Nickenig, Henk Garritsen, et al.. (2004). Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines. The Hematology Journal. 5(1). 61–68. 7 indexed citations
20.
Lenz, Georg, Grit Hutter, Wolfgang Hiddemann, & Martin Dreyling. (2004). Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Annals of Hematology. 83(10). 628–33. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana I. Sáez Breakdown of academic impact, for papers by Hilka Rauert‐Wunderlich Breakdown of academic impact, for papers by Isabel Romero-Camarero Breakdown of academic impact, for papers by Hannelore Madle Breakdown of academic impact, for papers by Viktor Ljungström Breakdown of academic impact, for papers by G Stranks Breakdown of academic impact, for papers by Irina Idler Breakdown of academic impact, for papers by Francis LeBlanc Breakdown of academic impact, for papers by Kerstin Dietze Breakdown of academic impact, for papers by Tatjana Walther
Rankless by CCL
2026